Veterinary Injectable Devices Market Trends

  • Report ID: 871
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT

Veterinary Injectable Devices Market Growth Drivers and Challenges:

Growth Drivers

  • Growing Demand for Animal Healthcare – The focus on animal health and well-being has led to an increase in demand for animal care, which includes the use of injectable medicinal products. The increasing demand for veterinary injectable medicinal products is driving a more proactive attitude by pet owners and animal farmers to seek preventive and curative treatment options. With about 15% of the veterinary injectable devices market at the time, Zoetis had the greatest share in the animal healthcare industry. Boehringer Ingelheim, the second-placed business, had almost 10% of the industry.

  • Advancements in Technology - Significant progress in the development of device design, materials, and features has been made in the animal injection device market. Innovative injectables offering improved accuracy, convenience of use, and safety for both animals and users have been developed by manufacturers. These developments have improved the efficiency and effectiveness of animal health treatments.

  • Increasing Prevalence of Zoonotic Diseases – Due to the possibility of spreading infections, an increase in pet ownership puts human health at risk. Zoonotic is an illness that can be passed on from animals to humans. The number of zoonotic diseases worldwide is therefore increasing rapidly. According to research by the WHO, zoonotic diseases cause millions of deaths and about a billion cases of illness each year.

Challenges

  • Stringent Regulatory Supplies – A strict regulatory regime governing the approval and marketing of injectable medicinal products and devices is applicable to the animal health industry. Compliance with these provisions may present challenges to manufacturers and limit market development, which can take a substantial amount of time and cost.

  • High Cost of Veterinary Care

  • Injuries and Infections due to Needles

Base Year

2025

Forecast Period

2026-2035

CAGR

5.5%

Base Year Market Size (2025)

USD 981.36 million

Forecast Year Market Size (2035)

USD 1.68 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of veterinary injectable devices is estimated at USD 1.03 billion.

The global veterinary injectable devices market size was worth around USD 981.36 million in 2025 and is set to register a CAGR of more than 5.5%, exceeding USD 1.68 billion revenue by 2035.

The North America veterinary injectable devices market is projected to capture a 35% share by 2035, driven by increased spending on companion animals in the U.S.

Key players in the market include Boehringer Ingelheim International GmbH, NuGen Medical Devices Inc, NEOGEN Corporation, Phibro Animal Health, Zoetis Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos